High-Efficacy Therapy May Reduce Relapses in Active SPMS
But no difference in disability progression seen for high-efficacy versus low-efficacy therapy for secondary progressive multiple sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.